CEN ISO/TS 7552-1:2024

Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood - Part 1: Isolated RNA (ISO/TS 7552-1:2024) CEN ISO/TS 7552-1:2024

Publication date:   Jul 18, 2024

General information

60.60 Standard published   Nov 13, 2024

CEN

CEN/TC 140 In vitro diagnostic medical devices

Technical Specification

11.100.10   In vitro diagnostic test systems

Buying

Draft

Language in which you want to receive the document.

Scope

This document specifies requirements and gives recommendations on the handling, storage, CTC enrichment and isolation, RNA isolation and storage, and documentation of venous whole blood specimens intended for the examination of RNA isolated from circulating tumour cells (CTCs) during the pre-examination phase before a molecular examination is performed.
This document is applicable to molecular in vitro diagnostic examinations including laboratory-developed tests performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions, and commercial organizations performing biomedical research, and regulatory authorities.
This document does not cover the isolation of cellular RNA directly from venous whole blood containing CTCs. This is covered in ISO 20186-1.
This document does not cover the isolation of specific white blood cells and subsequent isolation of cellular RNA therefrom. This document does not cover pre-analytical workflow requirements for viable CTC cryopreservation and culturing.
NOTE 1        The requirements given in this document can also be applied to other circulating rare cells (e.g. foetal cells).
NOTE 2        International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Life cycle

PREVIOUSLY

WITHDRAWN
CEN/TS 17390-1:2020

NOW

PUBLISHED
CEN ISO/TS 7552-1:2024
60.60 Standard published
Nov 13, 2024